Fig. 3.
Adjusted probabilities (from Cox regression model) of survival after diagnosis of CML in persons receiving HLA-identical sibling bone marrow transplants within 1 year of diagnosis or nontransplant therapy with hydroxyurea or interferon.
Adjusted probabilities (from Cox regression model) of survival after diagnosis of CML in persons receiving HLA-identical sibling bone marrow transplants within 1 year of diagnosis or nontransplant therapy with hydroxyurea or interferon.
